Status:
UNKNOWN
The Effectiveness of Continuous Glucose Monitoring in Diabetes Treatment for Infants and Young Children
Lead Sponsor:
Seattle Children's Hospital
Collaborating Sponsors:
The Gerber Foundation
Medtronic
Conditions:
Diabetes Mellitus, Type I
Eligibility:
All Genders
3-3 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to see if the use of a real-time glucose sensor improves diabetes control in young children (less than 4 years old) with Type I diabetes when they are initiated on insulin...
Detailed Description
A randomized controlled clinical trial involving patients 0-3 yrs old with type 1 diabetes. After successful screening the subjects will be randomized into one of two groups: a CSII group alone and a ...
Eligibility Criteria
Inclusion
- Children less than 4 years of age with Type I diabetes for at least 3 months
Exclusion
- Children greater than 4 years of age
- Monogenic diabetes
Key Trial Info
Start Date :
November 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2014
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT00875290
Start Date
November 1 2008
End Date
November 1 2014
Last Update
August 5 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seattle Children's Hospital
Seattle, Washington, United States, 98105